Glucosalin 2:1 Baxter Soluzione per infusione

Country: Շվեյցարիա

language: իտալերեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

buyitnow

PIL PIL (PIL)
06-05-2024
SPC SPC (SPC)
06-05-2024

active_ingredient:

glucosio, natrii chloridum

MAH:

Baxter AG

ATC_code:

B05BB02

INN:

glucose, natrii chloridum

pharmaceutical_form:

Soluzione per infusione

composition:

glucosum 33 g, natrii chloridum 3 g corresp. natrium 51 mmol et chloridum 51 mmol, aqua ad iniectabile q.s. ad solutionem pro 1000 ml corresp. 555 kJ.

class:

B

therapeutic_group:

Synthetika

therapeutic_area:

Parenterale di Liquido e apporto calorico

authorization_status:

zugelassen

authorization_date:

1984-09-08

documents_in_other_languages

SPC SPC գերմաներեն 24-10-2018
PIL PIL ֆրանսերեն 06-05-2024
SPC SPC ֆրանսերեն 22-10-2018